Jemma Arakelyan: Important Manifesto after the first Global Summit on War and Cancer organized by ICC and OncoDaily
Jemma Arakelyan shared on LinkedIn:
“It took us 8 months to publish this important Manifesto after the first Global Summit on War and Cancer organized by the Institute of Cancer and Crisis (ICC) and OncoDaily.
I am humbled to have an opportunity to work with an incredible team of authors including the Director General of WHO Tedros Adhanom Ghebreyesus, Princess Dina Mired, Richard Sullivan, Mark Lawler, Prof. Andreas Charalambous, Arman Kacharian, Alexandra Mueller, Christos Tsagkaris, Enrique Sot-Perez-de-Celis, Julie Gralow, Mulugeta Yimer, Layth Mula-Hussain, Khaled Ghanem, Nazik Hammad, Stella Arakelyan, Zeena Salman, M. Tezer Kutluk, Henrik Grigoryan, Andre Ilbawi, Bente Mikkelsen, World Health Organization, Gevorg Tamamyan, Jemma Arakelyan.
These global leaders in oncology, global health, and humanitarian aid have come together to highlight the critical challenges faced by cancer patients living in war zones and other conflict-affected regions.
We’re grateful to The Lancet for publishing this Manifesto, which we hope will drive much-needed action and policy change to support cancer care access and quality in some of the world’s most vulnerable communities.
Please take a moment to read and share this important piece widely.”
A manifesto on improving cancer care in conflict-impacted populations
Authors: Tedros Adhanom Ghebreyesus, Dina Mired, Richard Sullivan, Alexandra Mueller, Andreas Charalambous, Arman Kacharian, Christos Tsagkaris, Enrique Soto-Perez-de-Celis, Henrik Grigoryan, Julie Gralow, Andre Ilbawi, Khaled Ghanem, Layth Mula-Hussain, Bente Mikkelsen, Mulugeta Yimer, Nazik Hammad, Stella Arakelyan, Tezer Kutluk, Zeena Salman, Mark Lawler, Gevorg Tamamyan, Maria V Babak and Jemma Arakelyan.
Source: Jemma Arakelyan/LinkedIn
Dr. Jemma Arakelyan is a medical oncologist and the chief executive officer of The Institute of Cancer and Crisis. She is a Ph.D. candidate at the City University of Hong Kong. Her research focuses on developing new anticancer treatments and understanding the underlying mechanisms of cancer progression.
In addition to her academic pursuits, she is an active member of several scientific organizations, including the European School of Oncology (ESO), where she served as an ambassador in Armenia from 2020-2022. Dr. Arakelyan is also the president of the Institute of Cancer and Crisis. The Institute is dedicated to promoting awareness and support for cancer patients facing critical situations like war, pandemic, etc.